JY
VTGN icon

Jeff Yass’s VistaGen Therapeutics VTGN Stock Holding History

Jeff Yass’s Portfolio VTGN Stock Details VTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$95.5K Buy
415,400
+375,000
+928% +$226K ﹤0.01% 12530
2026
Q1 		$23K Sell
40,400
-375,000
-90% -$228K ﹤0.01% 12832
2025
Q4 		$274K Buy
415,400
+184,100
+80% +$665K ﹤0.01% 10157
2025
Q3 		$821K Buy
+231,300
New +$691K ﹤0.01% 7816
2025
Q1 		– Sell
-55,700
Closed -$164K – 13550
2024
Q4 		$164K Sell
55,700
-7,200
-11% -$20.3K ﹤0.01% 10944
2024
Q3 		$189K Sell
62,900
-147,600
-70% -$504K ﹤0.01% 10514
2024
Q2 		$733K Sell
210,500
-44,800
-18% -$194K ﹤0.01% 7311
2024
Q1 		$1.35M Sell
255,300
-54,500
-18% -$262K ﹤0.01% 6225
2023
Q4 		$1.59M Sell
309,800
-105,700
-25% -$400K ﹤0.01% 5860
2023
Q3 		$2.18M Buy
415,500
+401,100
+2,785% +$1.78M ﹤0.01% 4960
2023
Q2 		$26.9K Buy
+14,400
New +$50.5K ﹤0.01% 11556
2022
Q4 		– Sell
-5,367
Closed -$24K – 13794
2022
Q3 		$24K Buy
5,367
+1,944
+57% +$19.3K ﹤0.01% 12537
2022
Q2 		$90K Buy
+3,423
New +$121K ﹤0.01% 11567
2022
Q1 		– Sell
-393
Closed -$23K – 14076
2021
Q4 		$23K Sell
393
-210
-35% -$13.7K ﹤0.01% 12803
2021
Q3 		$50K Buy
+603
New +$52.4K ﹤0.01% 12350

Other funds holding VTGN

CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
LM
Luminus Management Houston, Texas $146M AUM 27.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Jeff Yass's VTGN Position: Q2 2026 in Review

Jeff Yass sold out of VistaGen Therapeutics (VTGN) in Q2 2026, closing a stake of 142,607 shares — an estimated $86K sold.

Jeff Yass first reported a position in VTGN in Q4 2017 and held it in 25 quarters. The position peaked at $1.53M in Q1 2024. 49 funds tracked by Wall St. Rank hold VTGN as of Q2 2026.

  • Jeff Yass reported no remaining VistaGen Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 142,607 VistaGen Therapeutics shares in Q2 2026, an estimated $86K.
  • Jeff Yass first reported a position in VistaGen Therapeutics in Q4 2017 and held it in 25 quarters.
  • Jeff Yass's VistaGen Therapeutics position peaked at $1.53M in Q1 2024.
  • 49 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.